Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2025 00:50 ET | Source: Bio Usawa Inc

Bio Usawa Takes Strategic Step into Europe with New Subsidiary in Frankfurt, Germany

KIGALI, Rwanda and FRANKFURT, Germany and SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd (Rwanda) proudly announces the establishment of its new European subsidiary,...
September 24, 2025 07:00 ET | Source: EBD Group

BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders

MUNICH, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Excitement is building for the 31st annual edition of BIO-Europe, the premier partnering conference for the global biopharmaceutical industry, which will...
September 22, 2025 09:15 ET | Source: Longeveron

Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa

Longeveron hosting partnering discussions for its Alzheimer's disease stem cell therapy program at Cell & Gene Meeting on the Mesa.
June 26, 2025 09:05 ET | Source: Longeveron

Longeveron® Appoints Than Powell as Chief Business Officer

Than Powell appointed as Longeveron CBO to lead overall business strategy, Alzheimer's program partnering and HLHS program international strategy.
March 18, 2025 07:00 ET | Source: Angitia Incorporated Limited

Angitia Biopharmaceuticals Presents Data from Phase 1/2 Study of AGA111 at 2025 AAOS Annual Meeting

WOODLAND HILLS, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a global, clinical-stage biotechnology company focused on the discovery and development of innovative...
November 07, 2024 09:05 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

- Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - - Agreement Provides Additional Validation for Clearside’s Suprachoroidal Space...
November 01, 2024 13:00 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
August 29, 2024 07:30 ET | Source: Big4Bio

Inaugural Pre-JPM Partnering Week to Wrap Up 2024, Prepare for 2025

New life science partnering conference to debut that prepares and helps industry dealmakers and stakeholders for the JP Morgan Healthcare Conference week
November 01, 2023 07:00 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
October 18, 2022 02:00 ET | Source: Mendus AB

Mendus AB: Mendus secures manufacturing partner for establishing potential pivotal trial-stage and commercial production of DCP-001

TECH TRANSFER ALIGNS WITH CLINICAL DEVELOPMENT STRATEGY FOR DCP-001 Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today...